▮ Content Licensing

▮ Premium NEW

▮ More

EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q3 Earnings Report

By RTTNews Staff Writer ✉ | Published: 11/10/2020 4:12 PM ET

Below are the earnings highlights for CTI BioPharma Corp. (CTIC):

-Earnings: -$11.26 million in Q3 vs. -$10.05 million in the same period last year.
-EPS: -$0.15 in Q3 vs. -$0.17 in the same period last year.
-Analysts projected -$0.15 per share

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In December

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

Latest Updates on COVID-19

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

US Records Encouraging Figures In Key COVID Metrics

New US COVID Cases At Its Lowest Level In Nearly 5 Months

FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine

FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine

COVID-19: Drugs in Development

Polaris Recalls Ranger Off-Road Vehicles, PRO XD Utility Vehicles

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

Chipotle In Deal With E.l.f. For Vegan, Cruelty-free Makeup Collection

UK CMA Probes Apple Over Suspected Anti-competitive Behavior - Quick Facts

Kroger Q4 Adj. EPS Tops Estimates, But Revenue Miss

Retail Sales Poised For Growth In 2021, But How Much?

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q3 Earnings Report

Polaris Recalls Ranger Off-Road Vehicles, PRO XD Utility Vehicles

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

Chipotle In Deal With E.l.f. For Vegan, Cruelty-free Makeup Collection

UK CMA Probes Apple Over Suspected Anti-competitive Behavior - Quick Facts

Kroger Q4 Adj. EPS Tops Estimates, But Revenue Miss

Retail Sales Poised For Growth In 2021, But How Much?

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

Disney To Close At Least 60 North American Stores, To Focus Online

Wilton Brands Recalls 7 Sprinkles Products For Undeclared Milk

FDA Accelerates Efforts To Issue EUA For More COVID-19 Home Tests

Dollar Tree, Wendy's Q4 Revenues Miss Estimates

Boston Scientific To Buy Global Surgical Business Of Lumenis For $1.07 Bln Cash - Quick Facts

FDA Accelerates Efforts To Issue EUA For More COVID-19 Home Tests

FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals

Stock Alert: Vir Biotechnology Closes Enrollment In COVID-19 Vaccine Trial

Genesis Healthcare Announces Strategic Restructuring Plan

Lilly : Phase 3 Study On Baricitinib Meets Primary Endpoint Of Hair Regrowth

AstraZeneca, FibroGen: FDA To Convene Committee Meeting To Review Roxadustat In Anaemia Of CKD

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

Neurocrine Biosciences: Luvadaxistat Fails To Meet Primary Endpoint In Phase II INTERACT Study

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

EU Opens Formal Probe Against Teva For Anticompetitive Conduct - Quick Facts

Roche: FDA Approves Actemra/RoActemra For Systemic Sclerosis-associated Interstitial Lung Disease

Michaels Co. Agrees To Be Acquired By Apollo Global Management For Equity Value Of About $3.3 Bln

Canopy Growth Launches CBD Beverage Brand Quatreau In The U.S. - Quick Facts

FDA Expands Approval Of Pfizer's Lorbrena As Treatment For ALK-Positive Metastatic Lung Cancer

Twitter Prices $1.25 Bln Of Principal Amount Of 0% Convertible Senior Notes Due 2026

Neurocrine Biosciences: Luvadaxistat Fails To Meet Primary Endpoint In Phase II INTERACT Study

Chico's FAS Posts Wider Loss In Q4 - Quick Facts

Kohl`s Corp. Q4 adjusted earnings Beat Estimates

Sea Ltd Q4 adjusted earnings Miss Estimates

Target Q4 Comparable Sales Up 20.5% - Quick Facts

Target Corp. Q4 adjusted earnings Beat Estimates

RIT Capital Partners FY Profit Rises

Swiss Life FY20 Profit Down, Lifts Dividend; Confirms Targets - Quick Facts